Plasma Alzheimer's disease biomarker variability: Amyloid‐independent and amyloid‐dependent factors

We investigated factor-Alzheimer's disease plasma biomarker associations in a large Korean cohort. Hemoglobin and estimated glomerular filtration rate affect the biomarkers independently of brain amyloid beta (Aβ). Apolipoprotein E genotypes and body mass index status affect the biomarkers dependent on brain Aβ. Addition of Aβ-independent factors shows negligible effect in predicting Aβ positivity. Adjusting for Aβ-dependent factors shows a modest effect in predicting Aβ positivity.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-11-13
DOI
https://doi.org/10.1002/alz.14368
Citations
16
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
5.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma Alzheimer's disease biomarker variability: Amyloid‐independent and amyloid‐dependent factors

Jun Pyo Kim, Bo Kyoung Cheon, Duk Lyul Na, Jihwan Yun et al.
16 citations
Alzheimer s & Dementia
Alzheimer's disease research and treatments
5.22
article

Plasma Alzheimer's disease biomarker variability: Amyloid‐independent and amyloid‐dependent factors

Jun Pyo Kim, Bo Kyoung Cheon, Duk Lyul Na, Jihwan Yun, Fernando González‐Ortiz, Hongki Ham, Hyemin Jang, Kaj Blennow, Sang Won Seo, Sung Hoon Kang, Hee Jin Kim, Heejin Yoo, Young Ju Kim, Eun Hye Lee, Daeun Shin, Nicholas J. Ashton, Henrik Zetterberg
article en
16 citations

Abstract

We investigated factor-Alzheimer's disease plasma biomarker associations in a large Korean cohort. Hemoglobin and estimated glomerular filtration rate affect the biomarkers independently of brain amyloid beta (Aβ). Apolipoprotein E genotypes and body mass index status affect the biomarkers dependent on brain Aβ. Addition of Aβ-independent factors shows negligible effect in predicting Aβ positivity. Adjusting for Aβ-dependent factors shows a modest effect in predicting Aβ positivity.

Alzheimer s & DementiaVol. 21(1)
University of Science and Technology of China (CN), University of Wisconsin–Madison (US), King's College London (GB), Soonchunhyang University (KR), Korea University Medical Center (KR), Stavanger University Hospital (NO), Sahlgrenska University Hospital (SE), Samsung Medical Center (KR), Seoul National University Hospital (KR), Centre for Mental Health (GB), Sorbonne Université (FR), Pitié-Salpêtrière Hospital (FR), UK Dementia Research Institute (GB), Institut du Cerveau (FR), University College London (GB), Bucheon University (KR), Sungkyunkwan University (KR), University of Gothenburg (SE)
Alzheimer's Association, EU Joint Programme – Neurodegenerative Disease Research, Korea University Guro Hospital, European Commission, National Research Foundation, Korea University, National Research Foundation of Korea, Hjärnfonden, Vetenskapsrådet, Kirsten og Freddy Johansens Fond, Ministry of Science and ICT, South Korea, Fondation pour la Recherche sur Alzheimer, Samsung, Korea National Institute of Health
Good health and well-being
Openalex Percentile: Top 4%
Alzheimer's disease research and treatments
5.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.